TrialPloS one2019

Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian's with chronic myeloid leukemia.

Atalay Mulu Fentie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.